ArticleFrontiers in medicine2025

Efficacy and safety of efgartigimod PH20 SC for Sjögren's disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study).

Yushiro Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.